|
|
Post by silentbob on Apr 8, 2014 6:57:18 GMT -5
|
|
|
|
Post by silentbob on Apr 8, 2014 6:59:10 GMT -5
|
|
|
|
Post by silentbob on Apr 8, 2014 7:09:32 GMT -5
|
|
|
|
Post by otherottawaguy on Apr 8, 2014 8:25:30 GMT -5
4/8/2014 Brinson Patrick Initiated Coverage Outperform $12.00 |
|
|
|
Post by otherottawaguy on Apr 8, 2014 8:26:50 GMT -5
MannKind Corp MNKD Brinson Patrick Market Outperform $12.00 |
|
|
|
Post by otherottawaguy on Apr 8, 2014 8:27:32 GMT -5
Market Outperform Admin April 8, 2014 Brinson Patrick Initiates MannKind Corp at Market Outperform2014-04-08T12:06:13+00:00 Rating Changes, United States No Comment In a report published today, Brinson Patrick Initiated Coverage on shares of MannKind Corp (MNKD) with a Market Outperform rating and a price target of $12.00 “We would be buyers on recent weakness from the FDA’s decision to extend the PDUFA date for Afrezza to July 15, 2014. Recall, the AdCom voted 13 – 1 and 14 – 0 in favor of approving Afrezza for type-1 and type-2 diabetes, respectively. While the FDA is under no obligation to follow these recommendations, we have a high level of conviction for approval. We view the votes and recommendations as a best-case-scenario for Afrezza, and envision a major partnership announcement soon.” Brinson Patrick said “We see little risk to approval, despite the PDUFA extension. With much of the approval risk behind Afrezza, we see investor focus shifting to labeling, commercial partnership, and successful launch. With initial sales beginning in 1Q:15, we model 2025 Afrezza sales of $3.6B, driven by use in earlier-stage T2D. We expect the initial demand for Afrezza to be high considering statements made by the panel and open public hearing about its efficacy, safety, pharmacokinetics, and attractive size.” it added Shares of MannKind Corp (MNKD) closed at $6.32 on Monday. |
|
|
|
Post by otherottawaguy on Apr 8, 2014 8:29:05 GMT -5
SilentBob:
Just hate seeing articles disappear or drop behind a pay wall as we have seen in the past.
Hope you don't mind me riding your tailcoat,
OOG
|
|
